Catalyst Wire Dossier Catalyst Wire Dossier

Hypertonic saline 3% (nebulised)

Hypertonic saline 3%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hypertonic saline 3% (nebulised), covering 2013-05-31 to 2013-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis. [Phase 4]

See pricing